John Francis Fowler

John Francis Fowler's AcademicInfluence.com Rankings

John Francis Fowler

Medical

#905

World Rank

#1168

Historical Rank

Oncology

#28

World Rank

#29

Historical Rank

medical Degrees

John Francis Fowler

Philosophy

#3201

World Rank

#5236

Historical Rank

Logic

#1012

World Rank

#1629

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

John Francis Fowler's Degrees

Doctorate Medicine Stanford University
PhD Radiation Oncology Stanford University

Why Is John Francis Fowler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John Francis Fowler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Stereotactic body radiation therapy for inoperable early stage lung cancer. (2010) (2246)
The linear-quadratic formula and progress in fractionated radiotherapy. (1989) (2080)
Is α/β for prostate tumors really low? (2001) (578)
Image guidance for precise conformal radiotherapy. (2003) (491)
Loss of local control with prolongation in radiotherapy. (1992) (471)
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. (2007) (373)
The radiobiology of prostate cancer including new aspects of fractionated radiotherapy (2005) (325)
A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. (1985) (318)
The adverse effect of treatment prolongation in cervical carcinoma. (1995) (316)
What hypofractionated protocols should be tested for prostate cancer? (2002) (314)
A challenge to traditional radiation oncology. (2004) (284)
The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. (1976) (283)
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. (2010) (263)
A new approach to dose escalation in non-small-cell lung cancer. (2001) (262)
21 years of biologically effective dose. (2010) (247)
Effects of different ionizing radiations on human cells in tissue culture. III. Experiments with cyclotron-accelerated alpha-particles and deuterons. (1963) (245)
Is alpha/beta for prostate tumors really low? (2001) (231)
Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. (2012) (228)
Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial. (2011) (226)
Loss of biological effect in prolonged fraction delivery. (2004) (226)
Spinal cord tolerance for stereotactic body radiotherapy. (2010) (208)
Brief summary of radiobiological principles in fractionated radiotherapy (1992) (182)
Neutron dosimetry for biology and medicine (1978) (180)
Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. (1998) (166)
Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? (1986) (166)
A simple analytic derivation suggests that prostate cancer α/β ratio is low (2001) (164)
Radiobiological aspects of low dose rates in radioimmunotherapy. (1990) (160)
Radiosensitizers of hypoxic cells in solid tumors. (1976) (151)
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. (2011) (151)
Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked. (1991) (149)
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. (2002) (149)
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. (2010) (142)
Cell kinetic measurements in prostate cancer. (1997) (142)
The Effect of Divided Doses of 15 MeV Electrons on the Skin Response of Mice (1965) (136)
On cold spots in tumor subvolumes. (2002) (134)
Biological Factors Influencing Optimum Fractionation in Radiation Therapy (2001) (134)
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. (1996) (132)
Experiments with fractionated x-ray treatment of the skin of pigs. (1963) (131)
Review: total doses in fractionated radiotherapy--implications of new radiobiological data. (1984) (128)
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. (1992) (125)
Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. (2003) (125)
Non-small cell lung tumors repopulate rapidly during radiation therapy. (2000) (124)
Radiation-induced lung damage: dose-time fractionation considerations. (1990) (123)
How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. (1990) (122)
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer (2006) (119)
Feasibility study of helical tomotherapy for total body or total marrow irradiationa). (2005) (119)
Selective boosting of tumor subvolumes. (2000) (116)
Fractionation and dose-rate. II. Dose-time relationships in radiotherapy and the validity of cell survival curve models. (1963) (115)
How fast is repopulation of tumor cells during the treatment gap? (2002) (114)
Skin reactions in mice after multifraction x-irradiation. (1974) (99)
Feasibility study of helical tomotherapy for total body or total marrow irradiation. (2005) (99)
CyberKnife radiosurgery for stage I lung cancer: results at 36 months. (2007) (98)
Repair in mouse lung for up to 20 fractions of X rays or neutrons. (1985) (97)
Pulsed brachytherapy: the conditions for no significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy. (1992) (97)
Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. (1997) (91)
The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. (1997) (91)
Clinical Implementation of Adaptive Helical Tomotherapy: A Unique Approach to Image-Guided Intensity Modulated Radiotherapy (2006) (86)
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. (2010) (84)
Reduction in Radiation Dose to Lung and Other Normal Tissues Using Helical Tomotherapy to Treat Lung Cancer, in Comparison to Conventional Field Arrangements (2003) (83)
Recovery and repopulation in mouse skin as a function of time after x-irradiation. (1969) (82)
Fractionation with x rays and neutrons in mice: response of skin and C 3 H mammary tumours. (1972) (79)
Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. I. The biological and physical advantages and problems of neutron therapy. (1963) (78)
A murine model of lip epidermal/mucosal reactions to X-irradiation. (1983) (77)
Repair in mouse lung between multiple small doses of X rays. (1983) (77)
Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling. (2009) (76)
Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine. (1992) (75)
Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade. (2005) (75)
The number of patients required in a clinical trial. (1971) (74)
DIFFERENCES IN SURVIVAL CURVE SHAPES FOR FORMAL MULTI-TARGET AND MULTI-HIT MODELS (1964) (72)
Dose response curves for organ function or cell survival. (1983) (72)
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. (1992) (69)
Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer. (2012) (68)
A comment on proliferation rates in human prostate cancer. (2000) (67)
Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion. (1992) (66)
Should single or distributed parameters be used to explain the steepness of tumour control probability curves? (2003) (66)
Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. (2007) (66)
Recovery and repopulation in mouse skin after irradiation with cyclotron neutrons as compared with 250-Kv x-rays or 15-Mev electrons. (1966) (66)
Radiosensitization of C3H Mouse Mammary Tumours by a 2-Nitroimidazole Drug (1974) (66)
A review of hypoxic cell radiosensitization in experimental tumors. (1979) (66)
The effect of anaesthetics on blood perfusion in transplanted mouse tumours. (1975) (65)
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. (1976) (64)
Is the α/β ratio for prostate tumours really low and does it vary with the level of risk at diagnosis? (2013) (64)
Letter: Fractionation schedules and a quadratic dose-effect relationship. (1975) (64)
HYPOXIC CELL SENSITISERS IN RADIOTHERAPY (1976) (63)
The Effect of Multiple Small Doses of X Rays on Skin Reactions in the Mouse and a Basic Interpretation (1976) (63)
Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: A 6-year follow-up (2007) (62)
Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. (2009) (62)
Radiosensitization of Chinese hamster cells by oxygen and misonidazole at low X-ray doses. (1986) (61)
Optimum overall times II: Extended modelling for head and neck radiotherapy. (2008) (61)
A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma. (1994) (60)
Development of radiobiology for oncology—a personal view (2006) (60)
Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry. (1993) (60)
A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. (2001) (60)
Linear quadratics is alive and well: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852). (2008) (59)
Nuclear Particles in Cancer Treatment (1981) (59)
The effect of single and fractionated doses of x rays on the effective proportion of hypoxic cells in C 3 H mouse mammary tumours. (1972) (58)
Is repair of DNA strand break damage from ionizing radiation second-order rather than first-order? A simpler explanation of apparently multiexponential repair. (1999) (58)
Are gadolinium contrast agents suitable for gadolinium neutron capture therapy? (2005) (57)
Eighth annual Juan del Regato lecture. Chemical modifiers of radiosensitivity--theory and reality: a review. (1985) (57)
EXPERIMENTS WITH FRACTIONATED X-IRRADIATION OF THE SKIN OF PIGS. II. FRACTIONATION UP TO FIVE DAYS. (1965) (57)
Changes in mouse blood pressure, tumor blood flow, and core and tumor temperatures following nembutal or urethane anesthesia. (1976) (57)
Fractionated radiation therapy after Strandqvist. (1984) (56)
Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. (2001) (55)
La Ronde- radiation sciences and medical radiology (1983) (55)
Lung Metastases Treated by CyberKnife® Image-Guided Robotic Stereotactic Radiosurgery at 41 Months (2008) (55)
Non-standard fractionation in radiotherapy. (1984) (55)
Radiotherapy employing three fractions on each of twelve consecutive days. (1988) (55)
A new incomplete-repair model based on a 'reciprocal-time' pattern of sublethal damage repair. (1999) (54)
Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone (2004) (54)
Predicting realistic RBE values for clinically relevant radiotherapy schedules. (1997) (54)
Further investigations of the response of irradiated mouse skin. (1966) (54)
Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. (1990) (53)
Motexafin-Gadolinium Taken Up In vitro by at Least 90% of Glioblastoma Cell Nuclei (2006) (53)
A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma. (1995) (53)
The RBE for mouse skin irradiated with 3-MeV neutrons: single and fractionated doses. (1983) (52)
The proportion of hypoxic cells in a human tumor. (1977) (52)
The prospects for new treatments for prostate cancer. (2002) (51)
Re-analysis of the time factor in local control by radiotherapy of T3T4 squamous cell carcinoma of the larynx. (1991) (51)
WR-2721 protection of pneumonitis and fibrosis in mouse lung after single doses of x rays. (1984) (51)
Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. (1997) (49)
Why shorter half-times of repair lead to greater damage in pulsed brachytherapy. (1993) (49)
VII. Experiments on the Skin of Pigs with Fast Neutrons and 8 MV X Rays, including some Effects of Dose Fractionation (1963) (48)
Dose-rate effects: some theoretical and practical considerations. (1960) (48)
Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals. (1992) (47)
The measurement of blood perfusion in experimental tumors by uptake of 86Rb. (1974) (47)
Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. (1994) (47)
Helical Tomotherapy as a Means of Delivering Accelerated Partial Breast Irradiation (2004) (46)
VIII General Review (1963) (46)
Experimental animal results relating to time-dose relationships in radiotherapy and the "ret" concept. (1971) (46)
Fractionation in medium dose rate brachytherapy of cancer of the cervix. (1996) (45)
Kinetics of repair in the spinal cord of the rat. (1997) (45)
IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult (2009) (45)
Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol. (1995) (43)
Optimum fractionation in X-ray treatment of C3H mouse mammary tumours. (1974) (43)
Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. (1991) (43)
THE ESTIMATION OF TOTAL DOSE FOR DIFFERENT NUMBERS OF FRACTIONS IN RADIOTHERAPY. (1965) (42)
The Incidence of Lung Metastases in C3h Mice after Treatment of Implanted Solid Tumours with X-rays or Surgery (1974) (42)
Cell Proliferation Kinetics and Radiation Therapy (1977) (42)
The Effect of Irradiating a Transplanted Murine Lymphosarcoma on the Subsequent Development of Metastases (1973) (41)
Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int j radiat oncol biol phys 2007;68:1491-1495). (2008) (40)
Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer. (1995) (40)
Misonidazole in fractionated radiotherapy: are many small fractions best? (1980) (40)
Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents. (1984) (40)
Confirmation of improved local-regional control with altered fractionation in head and neck cancer. (2000) (40)
Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy. (1993) (39)
Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors (2007) (38)
Clinical radiation doses for spinal cord: the 1998 international questionnaire. (2000) (38)
Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot? (1998) (37)
T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control. (1994) (37)
Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx. (1990) (37)
The linear quadratic fit for lung function after irradiation with X-rays at smaller doses per fraction than 2 Gy. (1986) (37)
Brain tumour detection using radioactive arsenic. (1961) (37)
Repair in mouse lung of multifraction X rays and neutrons: extension to 40 fractions. (1985) (37)
Seventh interim progress report of the british institute of radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx. (1978) (36)
Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma (1995) (36)
Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC (2005) (35)
Increased collagen and fluid content of mouse kidneys at 9 months after single or fractionated X irradiation. (1984) (35)
ARCON--current status: summary of a workshop on preclinical and clinical studies. (1997) (35)
Repair between Dose Fractions: A Simpler Method of Analyzing and Reporting Apparently Biexponential Repair1 (2002) (34)
Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy. (2010) (34)
Intervals between multiple fractions per day. Differences between early and late radiation reactions. (1988) (34)
Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice. (1975) (33)
Low radioprotection by thiol in lung: the role of local tissue oxygenation. (1983) (33)
Time-dose relationships in radiotherapy. (1970) (33)
What can we expect from dose escalation using proton beams? (2003) (32)
Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison. (2009) (32)
Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer. (1991) (32)
Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck. (2010) (32)
Cytotoxic Insult to Tissue (1983) (32)
Hypoxic cell sensitisers in radiotherapy. (1976) (31)
The response of mouse skin to fractionated x rays. (1975) (31)
Walking forward: the South Dakota Native American project. (2005) (31)
Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582. (1976) (31)
Low doses per fraction in radiotherapy: a definition for "flexure dose". (1983) (30)
Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals. (2000) (30)
Dose-Effect Relationships for Radiation Damage to Organized Tissues (1963) (30)
Repair kinetics in mouse lung after multiple X-ray fractions per day. (1988) (30)
Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation. (1993) (30)
The uptake of rubidium-86 in mouse kidneys irradiated with fractionated doses of x rays. (1975) (30)
The time course of radioprotection by WR 2721 in mouse skin. (1982) (29)
Are half-times of repair reliably shorter for tumors than for late normal-tissue effects? (1995) (29)
Practical and theoretical considerations in the use of the mouse foot system to derive epithelial stem cell survival parameters. (1979) (29)
Intercomparisons of new and old schedules in fractionated radiotherapy (1992) (28)
Caution on the use of altered fractionation for nasopharyngeal carcinoma. (1999) (28)
What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer (2013) (27)
Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation. (2008) (27)
How low is the α/β ratio for prostate cancer? in regard to Wang et al., IJROBP 2003;55:194–203 (2003) (27)
Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results. (1993) (27)
Is there a loss of repair capacity in mouse lungs with increasing numbers of dose fractions? (1983) (27)
Radiosensitization of solid tumors by nitroimidazoles. (1978) (26)
Comment on "Magical protons?" editorial by Goitein (Int J Radiat Oncol Biol Phys 2008;70:654-656). (2008) (26)
The radiation pneumonitis syndrome in half-body radiation therapy. (1978) (25)
Repair kinetics in mouse lung: a fast component at 1.1 Gy per fraction. (1989) (25)
Dose reduction factors when increasing dose rate in LDR or MDR brachytherapy of carcinoma of the cervix. (1997) (24)
New data on the value of α/β—evidence mounts that it is low (2004) (24)
Keynote address: integration of cytostatic agents and radiation therapy: a different approach to "proliferating" human tumors. (1991) (24)
The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate. (2002) (24)
Theoretical simulation of oxygen tension measurement in the tissue using a microelectrode: II. Simulated measurements in tissues. (2002) (24)
Practical Time-Dose Evaluations, or How to Stop Worrying and Learn to Love Linear Quadratics (2011) (24)
Modeling Dose and Local Control in Radiotherapy (1995) (24)
Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry. (1993) (24)
Regulation of Epidermal Stem Cells (1976) (23)
Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy. (2010) (23)
Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer. (2011) (23)
Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. II. Radiosensitization of human colon cancer cells by bromodeoxyuridine. (1992) (22)
Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules. (1996) (22)
On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours. (2003) (22)
Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation. (2013) (22)
A drug for improved radiosensitization in radiotherapy. (1980) (22)
Normal tissue reactions in the British Institute of Radiology Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the laryngo-pharynx by radiotherapy. (1991) (22)
Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour. (1977) (22)
Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. (1978) (21)
The first James Kirk memorial lecture. What next in fractionated radiotherapy? (1984) (21)
Stereotactic Body Radiation Therapy in Non–Small-Cell Lung Cancer: Linking Radiobiological Modeling and Clinical Outcome (2011) (20)
The best radiotherapy for the treatment of prostate cancer involves hypofractionation. (2006) (20)
Three or five fractions per week: treated on alternate treatment days. (1969) (20)
Medium-dose-rate brachytherapy of cancer of the cervix: preliminary results of a prospectively designed schedule based on the linear-quadratic model. (1999) (20)
Further analysis of radiobiological parameters from the First and Second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy. (1995) (20)
Idealized versus realized overall treatment times. (1994) (20)
Letter in response to "Optimization of radiation therapy and the development of multileaf collimation" by Anders Brahme. (1994) (19)
The predictive value of tumor classification compared with results of the british institute of radiology fractionation trial in the treatment of laryngopharyngeal carcinoma (1990) (19)
The effect of low-dose pre-operative X-irradiation of implanted mouse mammary carcinomas on local recurrence and metastasis. (1976) (19)
Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate? (1997) (19)
The volume effect in radiotherapy. (1993) (19)
The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot). (1995) (18)
Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer. (2005) (17)
'Fading times' required for apparently complete repair in irradiated tissues assuming the linear quadratic model of dose response. (1986) (17)
Don't squeeze hypofractionated schedules into too-short overall times. (2009) (17)
Modelling altered fractionation schedules. (1992) (17)
Radiation Effects on Normal Tissues (1977) (17)
Early and late effects in mouse lung and rectum. (1982) (17)
Impact of Dose Hot Spots on Spinal Cord Tolerance following Stereotactic Body Radiotherapy: A Generalized Biological Effective Dose Analysis (2012) (16)
Fractionation and glottic carcinoma. (1997) (16)
New horizons in radiation oncology. Presidential address, April 13, 1978 (1979) (16)
Current aspects of radiobiology as applied to radiotherapy. (1972) (16)
Effect of cyclophosphamide or x-rays on spontaneously occurring metastases from tumors transplanted into the tails of mice. (1981) (16)
High-dose-rate brachytherapy-. High-dose, high-tech, and high results. (2003) (16)
Image-Guided Radiation Therapy Committee (2001) (15)
Pion and Heavy Ion Radiotherapy: Pre-Clinical and Clinical Studies (1983) (15)
Comparison of tumour cure (local control) with regrowth delay in mice. (1980) (15)
Gastrointestinal protein loss in severe malabsorption complicated by idiopathic (hypercatabolic) hypoproteinaemia. (1959) (15)
Abstract19: Dose-per-Fraction Escalation for Localized Prostate Cancer - A Multi-Institutional Phase I/II Trial (2006) (15)
A Phase I/II Trial of Dose-per-Fraction Escalation for Prostate Cancer (2007) (15)
Repair factors for multifraction irradiations. (1984) (15)
Tumor cell kinetics using two labels and flow cytometry. (1994) (14)
Continuous infusion of halogenated pyrimidines. (1991) (14)
Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose. (1992) (14)
Hypoxic cell sensitizers: early or late in fractionated therapy? (1978) (14)
Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration. (1983) (14)
Dose rate in external beam radiotherapy for prostate cancer: an overlooked confounding variable? (2003) (14)
RATIONALE OF DOSE FRACTIONATION. (1969) (14)
Is there a future for cell kinetic measurements using IdUrd or BdUrd? (2001) (14)
Yes, the α/β ratio for prostate cancer is low or “methinks the lady doth protest too much … about a low α/β that is” (2002) (14)
Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. VI. The RBE of fast neutrons in producing intestinal and skin injury in rats. (1963) (13)
A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy. (2014) (13)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy Committee. (2001) (13)
Biosynthesis of Cholesterol in Familial Hypercholesterolaemic Xanthomatosis (1959) (12)
Salvage surgery following irradiation with different fractionation regimes in the treatment of carcinoma of the laryngo pharynx: experience gained from a British Institute of Radiology Study (1992) (12)
Steepness of dose-response curve for larynx cancer. (1994) (12)
RBE values for regrowth of C3H mouse mammary carcinomas after single doses of cyclotron neutrons or X-rays. (1973) (11)
Protection against late and early damage in irradiated mouse lung by WR 2721 (1982) (11)
The use of tantalum 182 in the treatment of early bladder carcinoma. (1956) (11)
Response predictors in radiotherapy: a review of research into radiobiologically based assays. (1988) (11)
In response to Drs. Dale and Jones (2002) (11)
The effect of overall treatment time in radiotherapy for localized prostate carcinoma. (1991) (11)
Doses and fractionation schemes to be employed in clinical trials of high-LET radiations (1979) (10)
Effect of fractionation in stereotactic body radiation therapy using the linear quadratic model. (2013) (10)
Dissociation of early and late damage in mouse lung (1980) (10)
Optimizing the dose rate and technique in cervical carcinoma--balancing cases versus complications. (1994) (10)
Dose-rate effects on mice and rats in the range 2 to 340 rads/minute. (1960) (10)
Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy. (1994) (10)
What to do withneutrons in radiotherapy: A suggestion (1988) (10)
Rapid repopulation in radiotherapy: Debate on mechanism (1992) (9)
The linear-quadratic model (1988) (9)
Letter: A rapid method for the determination of tumour RBE. (1974) (9)
Second progress report of the British Institute of Radiology fractionation working party. (1968) (9)
Lung radioprotection by WR-2721 at low X-ray doses per fraction. (1984) (9)
Physical comparison of gamma camera and two-headed scanner: figures of merit and times required for threshold detection of spherical sources. (1968) (9)
Relative effectiveness of 12-hourly fractionation and a non-uniform x-ray schedule in the optimum fractionation of C3H mouse mammary tumours. (1975) (9)
40 years of radiobiology: its impact on radiotherapy. (Eighteenth Douglas Lea Lecture) (1984) (9)
First interim progress report on the second British Institute of Radiology Fractionation Study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngopharynx. (1989) (9)
Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. (1995) (9)
Biologically effective doses in radiotherapy of cervical carcinoma*. (2004) (9)
International Clinical Trials in Radiation Oncology. Radiobiology. (1988) (8)
The limiting radiosensitisation of tumours by S-phase sensitisers. (1996) (8)
Alpha, beta, and surviving fraction. (1992) (8)
Dose-rate effects in intensity modulated radiation therapy (2001) (8)
Local control versus dose or overall time: from coefficients to percentages. (1994) (8)
Hypoxic cell radiosensitizers. (1976) (8)
Recruitment, follow-up and analysis times in clinical trials of cancer treatment: a case study. (1990) (8)
Third progress report on the British Institute of Radiology fractionation study on 3F-week or 5F-week treatment of larynx and pharynx. (1970) (8)
A cautionary note on the resolution of paraquat lung damage after radiotherapy. (1985) (8)
Comments on "Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer". (2005) (8)
Mapping of physiological and trace elements with X-PEEM (2003) (8)
Short and long fractionated schedules in radiotherapy and a proposed improvement. (1987) (8)
90Y.B72.3 against pancreatic cancer: dosimetric and biological analysis. (1990) (8)
Point/Counterpoint. The best radiotherapy for the treatment of prostate cancer involves hypofractionation. (2006) (8)
How low is the alpha/beta ratio for prostate cancer? In regard to Wang et al., IJROBP 2003;55:194-203. (2003) (8)
Radiotherapy with three fractions per day for twelve consecutive days for tumors of the thorax, head and neck. (1988) (8)
The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem (the real conclusions): in regard to Mu et al. Radiotherapy on Oncology 2003; 68: 181-87. (2004) (8)
Individualized higher dose of 70–75 Gy using five-fraction robotic stereotactic radiotherapy for non-small-cell lung cancer: A feasibility study (2011) (7)
Carcinoma of the lung: hyperfractionation or resection and chemotherapy? (1991) (7)
New data on the value of alpha/beta--evidence mounts that it is low. (2004) (7)
Survival of mouse type B spermatogonia for the study of the biological effectiveness of 1 MeV, 2.3 MeV and 5.6 MeV fast neutrons. (1987) (7)
Erratum: A challenge to traditional radiation oncology (International Journal of Radiation Oncology Biology (2004) 60 (1241-1256)) (2005) (7)
6 Radiation repair mechanisms (2007) (7)
Variation of RBE with Dose and Dose Rate for a Miniature El ectronic Brachytherapy Source (2004) (7)
The effect of hypoxia on the skin response of mice to divided doses of 15 MeV electrons. (1967) (7)
Scientific perspectives on recent progress in radiation oncology (1986) (7)
An experimental evaluation of three preoperative radiation regimens for resectable rectal cancer (2002) (6)
The effect of fractionated doses of neutrons on C3H mouse mammary tumours. (1974) (6)
Standardized treatment planning for high dose rate vaginal cuff brachytherapy (1995) (6)
Short-course neutron therapy for advanced head and neck cancer. (1988) (6)
Yes, the alpha/beta ratio for prostate cancer is low or "methinks the lady doth protest too much...about a low alpha/beta that is". (2002) (6)
Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice. (1982) (6)
When Is a "BED" not a "BED"?-When it is an EQD2: In regard to Buyyounouski et al. (Int J Radiat Oncol Biol Phys 2010;76:1297-1304). (2010) (6)
Summary of EORTC Workshop on Progress in High-L.E.T. Radiation Therapy (1985) (6)
A Comparison of the Normal-tissue Reactions in Patients Treated with Either 3F/Wk or 5F/Wk in the BIR Trial of Radiotherapy for Carcinoma of the Laryngo-pharynx (1989) (6)
The effect of recovery from potentially lethal damage on the determination of reoxygenation in a murine tumour. (1979) (6)
Recent developments in radioisotope techniques: A symposium. III. The flow of blood in varicose veins. (1959) (5)
Changes in 32P counting-rate in human and animal tumours. (1968) (5)
Quantitative radiation histopathology. (1977) (5)
Fractionation in radiation therapy (1990) (5)
The average density of healthy lung. (1959) (5)
Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy (1996) (5)
Radioresponsiveness of malignant melanoma to fractionated irradiation. (1984) (5)
Is HDR brachytherapy for carcinoma of the uterine cervix high-throughput but high risk? (1998) (5)
High-dose-rate brachytherapy for cervical carcinoma. (1992) (5)
An analysis of the efficacy and safety of high dose rate as compared to low dose rate brachytherapy in the treatment of uterine cervical carcinoma (1993) (5)
Current Topics in Radiation Research (1969) (5)
Use of the linear-quadratic model to compare doses delivered to the bone marrow by 131-I-Lym-1 radioimmunotherapy (1995) (5)
American Investment Trusts (1930) (4)
The fundamental limits of information content in solid state image intensifying panels compared with other intensifying systems. (1960) (4)
The response of rapidly dividing tissues to acute or protracted exposure to ionizing radiation (1982) (4)
Greater radioprotection of late fibrosis than of early pneumonitis in mouse lung by WR-2721 (1982) (4)
DISTRIBUTIONS OF HIT-NUMBERS IN SINGLE TARGETS. (1967) (4)
The Denekamp Diadems&A Review of Julie's Achievements (2001) (4)
In reply to Dr. Lee. (2009) (4)
Developments in radiotherapy other than heavy particle beams. (1977) (4)
Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. VIII. General review. (1963) (4)
Dermatological applications of HDR using surface applicators using a shorter treatment schedule (2006) (4)
Preliminary Guidelines for Avoidance of Radiation-induced Myelopathy Following Spine Stereotactic Body Radiosurgery (SBRS) (2008) (4)
Time-variable dose rate in HDR stepping source brachytherapy. (1993) (4)
Late normal tissue complications: new insights. (1995) (4)
Sixth interim progress report of the British Institute of Radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx. (1978) (4)
Fractionation factors for late effects in head and neck cancers. (1992) (4)
Repair but not potentiation observed in mouse lung irradiated with neon ions. (1987) (4)
Three or five fractions per week for breast cancer. (1970) (3)
New approaches to radiation therapy in locally advanced carcinoma of the cervix. (1994) (3)
Principles of Fractionation in Radiotherapy (1988) (3)
Modeling the contribution of synchronous chemotherapy to the rate of grade 3 and 4 mucositis in locally advanced squamous cell carcinoma of the head and neck. (2009) (3)
Abstracts of ASTRO scientific papers to be presentedThe adverse effect of treatment prolongation in cervical carcinoma (1993) (3)
Summary of general discussion on radiotherapeutic aspects of the clinical application of fast neutrons. (1971) (3)
Rapid protein breakdown in idiopathic hypoproteinaemia. (1958) (3)
Dosimetric intercomparison in the British Institute of Radiology fractionation study of 3F/week versus 5F/week in radiotherapy of laryngo-pharynx cancer. (1990) (3)
The effects of some variables on arc therapy dosage distributions. (1958) (3)
Modifications of the delayed biopsy technique for human tumor proliferation kinetics (1991) (3)
In response to Dr. Denham (2002) (3)
The effect of recovery from potentially lethal damage on the determination of repair and repopulation in a murine tumour. (1985) (3)
Re-treatment Spinal Cord Tolerance for Spine Stereotactic Body Radiotherapy (2009) (3)
Influence of recovery, repopulation and reoxygenation of radiosensitivity of tumors and normal tissues (1974) (3)
Fundamental Aspects of LET in Radiobiology1 (1975) (3)
Comparison of iodine 124 and iodine 131 for thyroid ablation. (1963) (3)
Accelerated hypofractionation. (2005) (3)
Dose fractionation schedules--biologic aspects and applications to high LET radiotherapy. (1975) (3)
104 SPINAL CORD TOLERANCE FOR STEREOTACTIC BODY RADIOTHERAPY (2009) (2)
Comments on `Standard effective doses for proliferative tumours' (2000) (2)
P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC (2005) (2)
4th International Conference on Dose, Time and Fractionation in Radiation Oncology, at the University of Wisconsin, Madison, WI, USA, 16-19 September 1992. (1993) (2)
Radiotherapy using multiple fractions per day (1983) (2)
Pushing the frontiers of radiobiology: a sPecial feature in memory of sir oliver scott and Professor Jack fowler: review articles the many faces of mathematical modelling in oncology (2018) (2)
PD5-2-4: Phase I/II results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC (2007) (2)
135 : New Directional Brachytherapy Sources And Repair Half-Time Data Indicate Monotherapy for Intermediate Risk T2b and High Risk T2c Prostate Tumors (2006) (2)
Solid state image intensifiers: problems in design. (1959) (2)
In Reply to Ohri et al (2012) (2)
Cell cycle redistribution by fluorodeoxyuridine (fdurd) as a mechanism of fluoropyrmiidine radiosensttization. Supported by an ASTRO Research Fellowship (1993) (2)
How to efficiently model Tpot and why we should care (2002) (2)
Third International Meeting on Progress in Radio-Oncology (1985) (2)
RADIATION DOSIMETRY IN DIAGNOSTIC PROCEDURES. (1971) (2)
High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model (2001) (2)
FAST NEUTRON BEAMS FOR RADIOTHERAPY. (1971) (2)
In memoriam Tikvah Alper 1909-1995. (1995) (2)
Anaesthetics in the study of the microcirculation of tumours: pitfalls and uses. (1977) (2)
Pulsed brachytherapy as a substitute for continuous low dose rate: comment on Chen, Huang, Hall, and Brenner's paper. (1997) (2)
Problems in the design of a fluorescence meter for interstitial therapy, and a practical design of instrument. (1955) (2)
A Comment on Qi et al.: An Estimation of Radiobiological Parameters for Head-and-Neck and the Clinical Implications. Cancers, 2012, 4, 566-580 (2012) (2)
A "Red Shell" concept of increased radiation damage hazard to normal tissues just outside the PTV target volume. (2010) (2)
Neutrons for radiotherapy of resistant tumors: Interactions with low let (1986) (2)
Optimum overall treatment time in radiation oncology (2015) (2)
Radiobiology for the Radiologist. Eric J. Hall (1988) (2)
Proceedings: Optimum fractionation in X-ray treatment of C3H mouse mammary tumours. (1974) (2)
What to do with neutrons in radiotherapy: a suggestion. (1988) (1)
Radioimmunotherapy: dosimetric and biological analysis (1989) (1)
The eighteenth Douglas Lea lecture. 40 years of radiobiology: its impact on radiotherapy. (1984) (1)
Juliana Littbrand-Denekamp (1943-2000) (2002) (1)
High dose rate intracavitary (HDR-ICR) remote afterloading brachytherapy for inoperable carcinoma of the endometrium (1992) (1)
The effects of misonidazole on radiation injury in mouse spinal cord (1982) (1)
Developing aspects of radiation oncology. (1981) (1)
Applications to radiobiology and radiotherapy (1989) (1)
Novel radiotherapy schedules aid recovery of normal tissues after treatment. (2010) (1)
Response of the mouse mediastinum to single and fractionated X-rays. (1991) (1)
Kinetics of injury and repair to mammalian tissue by high-LET radiation. (1967) (1)
Bioeffect Modeling and equieffective dose concepts in radiation oncology: comments on Bentzen et al.'s paper from ICRU in Radiother Oncol 2012;105:266-268. (2013) (1)
APPLICATIONS OF FAST NEUTRON BEAMS IN RADIATION THERAPY. (1972) (1)
Small ionization chambers for direct reading of interstitial dose-rates. (1959) (1)
Cell kinetic measurements: principles, guidelines for treatment? (1999) (1)
The influence of tumor proliferation and treatment time on growth delay in human breast tumor xenografts treated with fractionated radiation (1993) (1)
P38 05 TP – IODODEOXYURIDINE: A MORE EFFICIENT RADIOSENSITIZER THAN BROMODEOXYURIDINE IN THE CLINICALLY-RELEVANT PORTION OF THE RADIATION SURVIVAL CURVE OF HUMAN CELLS (1991) (1)
The second Klaas Breur memorial lecture. La Ronde--radiation sciences and medical radiology. (1983) (1)
Juliana Littbrand-Denekamp (2001) (1)
62 : Hypofractionated Stereotactic Radiotherapy, 33.5Gy in Five Fractions, for Low Risk Prostate Cancer; Clinical Results (2006) (1)
Hospital Physics Technicians' Salaries (1967) (1)
Fifth progress report on the British Institute of Radiology fractionation trial of 3F-week or 5F-week treatment of larynx and pharynx. (1972) (1)
High-Dose-Rate (HDR) Brachytherapy for Facial Nonmelanoma Skin Cancer (NMSC) Using Custom-Made Molds and a Shortened Fractionation Schedule (2013) (1)
The radioprotecting drug WR 2721—time course experiments (1982) (1)
Post-operative high dose rate vaginal cuff irradiation: A phase I-II Protocol (1994) (1)
Radiobiology of pulsed dose rates (2000) (1)
The Calculation of an Integral Biologically Effective Dose in Fractionated Stereotactic Radiotherapy (1996) (1)
Hyperfractionated radiotherapy. (2015) (1)
PO-0724 REVISING THE RADIOBIOLOGICAL MODEL OF CHEMORADIATION IN HEAD AND NECK CANCER (2012) (0)
Conventional vs. hyperfractionated high dose rate endobronchial radiation (1990) (0)
IN MEMORIAM (2001) (0)
30 Biological effect of pulsed dose rate brachytherapy with stepping sources (1996) (0)
Optimum fractionation in radiotherapy--is shorter better? abstr. (1977) (0)
P15 07 MP – ADDING CONTINUOUS ESCALATION TO ACCELERATED HYPERFRACTIONATION FOR HEAD AND NECK CANCER (1991) (0)
What next in fractionated radiotherapy? (2007) (0)
Fourth Progress Report on the British Institute of Radiology fractionation study on 3F-week or 5F-week treatment of larynx and pharynx. (1970) (0)
Review of the basis of heavy particle therapy and past clinical trials (1973) (0)
Measurements of potential doubling time in primary prostate adenocarcinomas (1997) (0)
Fast neutron treatment of cervical lymph nodes. (1983) (0)
Letter to the editor. (1967) (0)
Letter to the Editor: Comments on comparison of in vitro and in vivo alfa/beta ratios for prostate cancer (2005) (0)
Locoregional tumor control in head and neck (H&N) cancer patients following hyperfractionated, accelerated radiotherapy with dose escalation (HARDE) (1994) (0)
Fractionation in radiation therapy - Part II - Radiobiological emphasis (1992) (0)
E-53. Helical tomotherapy: An innovative technological radiation therapeutic approach for lung cancer (2003) (0)
Book reviews (1963) (0)
Radiosensitisation of hypoxic cells in solid tumours in air-breathing c3h mice. Abstr. (1974) (0)
Early S-phase delay by fluorodeoxyuridine (FdUrd) as a mechanism of fluoropyrimidine radiosensitization (1992) (0)
High-LET radiation: clinical facilities available with neutron beams. (1973) (0)
Book reviewsOptimization of Human Cancer Radiotherapy (Lecture Notes in Biomathematics No. 42). By SwanGeorge W., pp. viii + 282, 1981 (Springer-Verlag, Berlin/Heidelberg/New York), DM 33.50. $15.60. ISBN 3–540–10865–3 (1983) (0)
Book reviewThermoluminescent Dosimetry. By CameronJ. R., SuntharalingamN. and KenneyG. N., pp. xxiii + 232, 125 illus., 1968 (London, University of Wisconsin Press), 71s. 3d. (1968) (0)
P15 08 MP – LOSS OF LOCAL CONTROL WITH INCREASING OVERALL TIME IN RADIOTHERAPY OF HEAD AND NECK CANCER (1991) (0)
Optimum overall treatment time in radiation oncology : how to stop worrying about time-dose evaluations and learn to love linear quadratics (2014) (0)
RECENT PROGRESS IN RADIOLOGIC TREATMENT WITH FAST NEUTRONS AND MESONS (1964) (0)
Confirmation of a low ratio of 1.5 Gy for prostate tumours (2001) (0)
Physics considerations in conversion from low dose rate to high dose rate gynecological intracavitory radiotherapy (1990) (0)
Radiation Biology and Cell Population Kinetics (2017) (0)
Advanced head and neck carcinoma in women: treatment outcomes may not improve with accelerated hyperfractionated radiotherapy. (2001) (0)
16th Paterson Symposium—Cellular mechanisms of long-term injury in tissue after radiation (1982) (0)
492Cell kinetic measurements in prostate cancer (1996) (0)
Uses and abuses of mathematical models in radioisotope or cell kinetic studies. (1971) (0)
In reply to Healy. (2013) (0)
The radioprotecting drug WR 2721 - time course studies (1981) (0)
Sequential comparison of ldr and hyperfractionated HDR EBRT for MAO (1991) (0)
Radiobiological data on time-dose relationships. (1973) (0)
EFFECTS OF RADIATION EXPOSURE IN THE THERAPEUTIC RANGE: TRUNCATED DOSES AND DOSE FRACTIONATION. (1970) (0)
Final Report of the BIR fractionation study (1990) (0)
Innovations in Radiation Oncology (1989) (0)
Kinetics of IdUrd incorporation after continuous exposure in-vivo☆ (1991) (0)
Julie Denekamp--her life and achievements (1943-2001): a brief account. (2001) (0)
[Relation of dosage-time in radiotherapy]. (1969) (0)
Dr. Fowler's Rebuttal of Dr. Rosenow's letter (1993) (0)
Response to Drs. Baumann and Beck-Bornholdt (1992) (0)
Reply (REBUTTAL) to H. P. Beck-Bornholdt et al.: Short overall times in radiotherapy (1991) (0)
Fourth International Meeting on Progress in Radio-Oncology Vienna, 28 September–1 October 1988 (1989) (0)
Fractionation in radiation therapy - Part I - Clinical emphasis, head and neck cancer (1992) (0)
Enhanced biological effect of pulsed dose rate if short half-times of repair are present in tissues (1996) (0)
385Continuous hyperfractionated accelerated radiotherapy with two daily fractions in advanced head and neck squamous cell carcinoma (HNSCC): A feasibility study (1996) (0)
Accelerated hyperfractionated radiotherapy for advanced head and neck cancer. Effect of shortening the median treatment duration by 14 days (2000) (0)
Radioactive isotopes in the localization of tumours (1970) (0)
Robert Katz: A Biographical Sketch (1989) (0)
Proposed universal standard for specifying schedules. (1992) (0)
Neutrons in radiotherapy--yes or no? (1973) (0)
SU‐E‐T‐17: Fractionation Effect on SBRT Using the Red Shell Concept and Linear Quadratic Model (2011) (0)
Fractionation — Show did we get where we are now? (1992) (0)
Cell population kinetics in four rodent tumours. Abstr. (1968) (0)
PLACE OF THERMOLUMINESCENCE DOSIMETERS AND IONIZATION CHAMBERS IN PRACTICAL DOSIMETRY. (1967) (0)
Comments on: Comparison of in vitro and in vivo α/β ratios for prostate cancer. Authors' reply (2005) (0)
The measurement of tumor blood perfusion and blood volume by means of radioactive tracers. (1974) (0)
Disease free survival and local control as a function of Tpot, LI and Ts (1997) (0)
New horizons in radiation oncology. Presidential address delivered on April 13, 1978 at The British Institute of Radiology Joint meeting and Annual Congress held at the RIBA, London W1. (1979) (0)
Isn't it reasonable to ask for fraction numbers? (2008) (0)
SU-EE-A1-02: Feasibility Study of Helical Tomotherapy for Total Body and Total Marrow Irradiation (2005) (0)
Fractionation Effect on SBRT Treatments using the Red Shell Concept and Linear Quadratic Model (2011) (0)
Nicolas John McNally 1939–1991 (1991) (0)
A comparison of the normal-tissue reactions in patients treated with either 3F/Wk or 5F/Wk in the BIR (British Institute of Radiology) trial of radiotherapy for carcinoma of the laryngo-pharynx. (1989) (0)
Thursday, November 12, 1992 7:15 – 8:45 a.m.Fractionation in radiation therapy — part I — clinical emphasis, head and neck cancer (1992) (0)
Potential advantages of high LET radiation. (1983) (0)
The choice of dose levels for high dose rate (HDR) gynecologic brachytherapy (1990) (0)
Introduction to Radiobiology by M. Tubiana, J. Dutreix, and A. Wambersie (1993) (0)
Reply to comments of Schulz (1975) (0)
Time-dose relationships and the ret concept (1971) (0)
ReviewNeutron Dosimetry. Vol. I: pp. 653; Vol. II: pp. 615; 1963 (Vienna, International Atomic Energy Agency), 78s.each volume. (1964) (0)
ANNOUNCEMENTS (1976) (0)
A simple indicator for the temperature-and-pressure correction. (1956) (0)
The influence of repair half times on the biological effect of PDR (2000) (0)
Advanced head and neck carcinoma in women (2001) (0)
Human Spinal Cord Re-irradiation Guidelines for Stereotactic Body Radiotherapy (2010) (0)
Proceedings: Radiosensitization of hypoxic cells in solid tumours in mice. (1975) (0)
Uptake of $sup 86$Rb in mouse kidneys irradiated with fractionated doses of x rays (1975) (0)
ABSORBED DOSES FROM $sup 133$Xe. Technical Memorandum No. 84. (1963) (0)
Book ReviewsThe Radiobiology of Human Cancer Radiotherapy. By AndrewsJ. R., pp. x + 271, 71 illus., 1968 (London, W. B. Saunders & Co. Ltd.), £8 1s. 6d. (1969) (0)
848 poster OPTIMUM FRACTIONATION – DEPENDS ON TUMOUR PROLIFERATION (2011) (0)
Advances in Cancer Research (1986) (0)
Accelerated fractionation (AF) in head and neck cancers. (1998) (0)
Summary of meeting on "Radiobiological modelling in treatment planning" at the BIR on 12 December 2006. (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John Francis Fowler?

John Francis Fowler is affiliated with the following schools:

Medical College of Wisconsin

John Francis Fowler's Academic­Influence.com Rankings

John Francis Fowler's Degrees

Why Is John Francis Fowler Influential?

John Francis Fowler's Published Works

Published Works

What Schools Are Affiliated With John Francis Fowler?

John Francis Fowler's AcademicInfluence.com Rankings